Caitlin M Hudac

Dr. Caitlin M Hudac

University of South Carolina, Columbia, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2011 in Journal of Child Psychology and Psychiatry
Verified
Journal Article
Closed access
PDF file
KPKevin A. Pelphrey
Kevin A. Pelphrey
SSSarah Shultz
Sarah Shultz
CHCaitlin M Hudac
Caitlin M Hudac
BWBrent C. Vander Wyk
Brent C. Vander Wyk

15 November 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MKMartha D. Kaiser
Martha D. Kaiser
CHCaitlin M Hudac
Caitlin M Hudac
SSSarah Shultz
Sarah Shultz
SLSu Mei Lee
Su Mei Lee
CCCeleste Cheung
Celeste Cheung
KPKevin A. Pelphrey
Kevin A. Pelphrey
Functional magnetic resonance imaging of brain responses to biological motion in children with autism spectrum disorder (ASD), unaffected siblings (US) of children with ASD, and typically developing (TD) children has revealed three types of neural signatures: ( i ) state activity, related to the state of having ASD that characterizes the nature of disruption in brain circuitry; ( ii ) trait activity, reflecting shared areas of dysfunction in US and children with ASD, thereby providing a promising neuroendophenotype to facilitate efforts to bridge genomic complexity and disorder heterogeneity; and ( iii ) compensatory activity, unique to US, suggesting a neural system–level mechanism by which US might compensate for an increased genetic risk for developing ASD. The distinct brain responses to biological motion exhibited by TD children and US are striking given the identical behavioral profile of these two groups. These findings offer far-reaching implications for our understanding of the neural systems underlying autism.

1 June 2009 in Psychological Science
Verified
Journal Article
Closed access
BWBrent C. Vander Wyk
Brent C. Vander Wyk
CHCaitlin M Hudac
Caitlin M Hudac
ECElizabeth J. Carter
Elizabeth J. Carter
DSDavid M. Sobel
David M. Sobel
KPKevin A. Pelphrey
Kevin A. Pelphrey

1 January 2013 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
TNTobias Nolte
Tobias Nolte
DBDanielle Z. Bolling
Danielle Z. Bolling
CHCaitlin M Hudac
Caitlin M Hudac
PFPeter Fonagy
Peter Fonagy
LMLinda Mayes
Linda Mayes
KPKevin A. Pelphrey
Kevin A. Pelphrey
Mentalizing, in particular the successful attribution of complex mental states to others, is crucial for navigating social interactions. This ability is highly influenced by external factors within one’s daily life, such as stress. We investigated the impact of stress on the brain basis of mentalization in adults. Using a novel modification of the Reading the Mind in the Eyes Test (RMET-R) we compared the differential effects of two personalized stress induction procedures: a general stress induction (GSI) and an attachment-related stress induction (ASI). Participants performed the RMET-R at baseline and after each of the two inductions. Baseline results replicated and extended previous findings regarding the neural correlates of the RMET-R. Additionally, we identified brain regions associated with making complex age judgments from the same stimuli. Results after stress exposure showed that the ASI condition resulted in reduced mentalization-related activation in the left posterior superior temporal sulcus (STS), left inferior frontal gyrus and left temporoparietal junction. Moreover, the left middle frontal gyrus and left anterior insula showed greater functional connectivity to the left posterior STS after the ASI. Our findings indicate that attachment-related stress has a unique effect on the neural correlates of mentalization.

1 April 2015 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
RHRoger Higdon
Roger Higdon
RERachel K. Earl
Rachel K. Earl
LSLarissa Stanberry
Larissa Stanberry
CHCaitlin M Hudac
Caitlin M Hudac
EMElizabeth Montague
Elizabeth Montague
EKEugene Kolker
Eugene Kolker
Complex diseases are caused by a combination of genetic and environmental factors, creating a difficult challenge for diagnosis and defining subtypes. This review article describes how distinct disease subtypes can be identified through integration and analysis of clinical and multi-omics data. A broad shift toward molecular subtyping of disease using genetic and omics data has yielded successful results in cancer and other complex diseases. To determine molecular subtypes, patients are first classified by applying clustering methods to different types of omics data, then these results are integrated with clinical data to characterize distinct disease subtypes. An example of this molecular-data-first approach is in research on Autism Spectrum Disorder (ASD), a spectrum of social communication disorders marked by tremendous etiological and phenotypic heterogeneity. In the case of ASD, omics data such as exome sequences and gene and protein expression data are combined with clinical data such as psychometric testing and imaging to enable subtype identification. Novel ASD subtypes have been proposed, such as CHD8, using this molecular subtyping approach. Broader use of molecular subtyping in complex disease research is impeded by data heterogeneity, diversity of standards, and ineffective analysis tools. The future of molecular subtyping for ASD and other complex diseases calls for an integrated resource to identify disease mechanisms, classify new patients, and inform effective treatment options. This in turn will empower and accelerate precision medicine and personalized healthcare.

5 October 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
RERachel K. Earl
Rachel K. Earl
TTTychele N. Turner
Tychele N. Turner
HMHeather C. Mefford
Heather C. Mefford
CHCaitlin M Hudac
Caitlin M Hudac
JGJennifer Gerdts
Jennifer Gerdts
RBRaphael A. Bernier
Raphael A. Bernier
DYRK1A is a gene recurrently disrupted in 0.1–0.5% of the ASD population. A growing number of case reports with DYRK1A haploinsufficiency exhibit common phenotypic features including microcephaly, intellectual disability, speech delay, and facial dysmorphisms. Phenotypic information from previously published DYRK1A cases (n = 51) and participants in an ongoing study at the University of Washington (UW, n = 10) were compiled. Frequencies of recurrent phenotypic features in this population were compared to features observed in a large sample with idiopathic ASD from the Simons Simplex Collection (n = 1981). UW DYRK1A cases were further characterized quantitatively and compared to a randomly subsampled set of idiopathic ASD cases matched on age and gender (n = 10) and to cases with an ASD-associated disruptive mutation to CHD8 (n = 12). Contribution of familial genetic background to clinical heterogeneity was assessed by comparing head circumference, IQ, and ASD-related symptoms of UW DYRK1A cases to their unaffected parents. DYRK1A haploinsufficiency results in a common phenotypic profile including intellectual disability, speech and motor difficulties, microcephaly, feeding difficulties, and vision abnormalities. Eighty-nine percent of DYRK1A cases ascertained for ASD presented with a constellation of five or more of these symptoms. When compared quantitatively, DYRK1A cases presented with significantly lower IQ and adaptive functioning compared to idiopathic cases and significantly smaller head size compared to both idiopathic and CHD8 cases. Phenotypic variability in parental head circumference, IQ, and ASD-related symptoms corresponded to observed variability in affected child phenotype. Results confirm a core clinical phenotype for DYRK1A disruptions, with a combination of features that is distinct from idiopathic ASD. Cases with DYRK1A mutations are also distinguishable from disruptive mutations to CHD8 by head size. Measurable, quantitative characterization of DYRK1A haploinsufficiency illuminates clinical variability, which may be, in part, due to familial genetic background.